Showing results (51-60 of 68) with videos related to
Sort By:
Pageof 7
Nature Medicine|August 13, 2021
Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trialTien Dam, Adam L Boxer, Lawrence I Golbe, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|December 31, 2014
Factors affecting longitudinal functional decline and survival in amyotrophic lateral sclerosis patientsHazuki Watanabe, Naoki Atsuta, Ryoichi Nakamura, et al.Journal of Neurology, Neurosurgery, and Psychiatry|August 13, 2013
Neck weakness is a potent prognostic factor in sporadic amyotrophic lateral sclerosis patientsRyoichi Nakamura, Naoki Atsuta, Hazuki Watanabe, et al.Journal of the Neurological Sciences|July 18, 2016
Japanese version of the ALS-FTD-Questionnaire (ALS-FTD-Q-J)Yasuhiro Watanabe, Emma Beeldman, Joost Raaphorst, et al.Neurobiology of Aging|January 9, 2016
Next-generation sequencing of 28 ALS-related genes in a Japanese ALS cohortRyoichi Nakamura, Jun Sone, Naoki Atsuta, et al.Brain Pathology (Zurich, Switzerland)|July 13, 2021
Multiple system atrophy variant with severe hippocampal pathologyTakashi Ando, Yuichi Riku, Akio Akagi, et al.PNAS Nexus|August 12, 2024
CHCHD2 P14L, found in amyotrophic lateral sclerosis, exhibits cytoplasmic mislocalization and alters Ca2+ homeostasisAya Ikeda, Hongrui Meng, Daisuke Taniguchi, et al.Journal of Neurology|January 20, 2020
Cognitive and behavioral status in Japanese ALS patients: a multicenter studyYasuhiro Watanabe, Joost Raaphorst, Yuishin Izumi, et al.Neurobiology of Aging|January 18, 2022
Mutation screening of the DNAJC7 gene in Japanese patients with sporadic amyotrophic lateral sclerosisGenki Tohnai, Ryoichi Nakamura, Naoki Atsuta, et al.Journal of Neurology, Neurosurgery, and Psychiatry|January 10, 2016
A rapid functional decline type of amyotrophic lateral sclerosis is linked to low expression of TTNHazuki Watanabe, Naoki Atsuta, Akihiro Hirakawa, et al.Pageof 7